marketreports

Pregabalin Market size is forecast to reach $890 Million by 2025, growing at a CAGR of 3.67% during the forecast period 2020-2025. Pregabalin, marketed under the brand name Lyrica among others, is a medication used to treat epilepsy, neuropathic pain, fibromyalgia, restless leg syndrome, and generalized anxiety disorder. Its use in epilepsy is as an add-on therapy for partial seizures. When used before surgery, it reduces pain but results in greater sedation and visual disturbances. Pregabalin dosage is usually oral. Rising prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders among the geriatric population suffering from neuropathic diabetes and major technological advancements in the manufacturing process of pregabalin has resulted in a surge in demand of Pregabalin across the globe. Major healthcare investments by big firms and various product launches by key glove manufacturers like Cipla Limited are some other factors driving the growth of the mark...